Bladder Cancer

News Bladder Cancer

• Certain bladder-cancer patients may be at high risk of disease recurrence despite bladder removal

  Patients with advanced bladder cancers that are surgically removed might need additional therapy to prevent recurrence in certain situations, a new UT Southwestern Medical Center study suggests. The five-year international study led by researchers at UT Southwestern validates the use of a marker pan more

• Risk re-classified for carcinogenic everyday substance: X-ray expert "decodes" diesel soot

  Since June 2012, it is official: The World Health Organisation (WHO) has classified diesel soot as a lung carcinogen. Artur Braun, a physicist at Empa and an X-ray spectroscopy expert, has made crucial contributions to analyzing the structure and composition of soot particles. Soot particles are dan more

• Photocure announces the achievement of the second transition milestone of EUR 1.5 million for Hexvix

  Photocure ASA announced the achievement of the second manufacturing transition milestone from Ipsen, its new strategic partner for commercializing Hexvix worldwide, excluding the US and Nordic region. This triggers a payment of EUR 1.5 million. Hexvix is Photocure’s flagship product to aid in diagno more

Publications Bladder Cancer

• Genetic variations in micro-RNA biogenesis genes and clinical outcomes in non-muscle-invasive bladder cancer

  Micro-RNAs (miRNAs) are small non-coding RNA molecules, which can act as either oncogenes or tumor suppressors. Dysregulated expression of miRNA genes have been implicated in the development of many different cancers. We hypothesize that genetic variations in miRNA biogenesis genes may be associate more

• Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer

  Bladder cancer results from the combined effects of environmental and genetic factors, smoking being the strongest risk factor. Evaluating absolute risks resulting from the joint effects of smoking and genetic factors is critical to assess the public health relevance of genetic information. Analyses more

• Network views for personalized medicine

  Clinical Proteomics has traveled long way pinpointing potential biomarkers for a variety of diseases. However, the absence of clinical implementation of proteomics findings has led to a frank evaluation and re‐consideration of applied practices in biomarker discovery, recruitment of technological more

Market studies Bladder Cancer

• IDL Biotech AB (IDL B) - Financial and Strategic SWOT Analysis Review

  IDL Biotech AB (IDL Biotech AB) is a Sweden based biotechnology company engaged in developing, manufacturing and marketing of in vitro diagnostics within the areas of oncology and bacteriology. The product pipeline of the company consists of TPS, TPAcyk, MonoTotal and UBC, which are cytokeratin tumo more

• Bladder Cancer – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Bladder Cancer - Pipeline Review, H1 2012', provides an overview of the Bladder Cancer therapeutic pipeline. This report provides information on the therapeutic development for Bladder Cancer, complete with latest updates, and special features on late-stage a more

• Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2012', provides an overview of the Muscle Invasive Bladder Cancer (MIBC) therapeutic pipeline. This report provides information on the therapeutic development for Muscle Invasive Bladder Cancer (MIBC more

Websites Bladder Cancer